Dr. George Marcellino, Vice President and Co-founder of OptiMedica, is widely known in the medical community, bringing more than twenty-five years experience in the medical device industry. He has coordinated a number of ophthalmic research efforts in areas such as Selective Laser Trabeculoplasty (SLT) for the treatment of Glaucoma, Photodynamic Therapy (PDT) for the treatment of Exudative Age-related Macular Degeneration, and Selective Retinal Therapy.
Prior to joining OptiMedica, Dr. Marcellino was Senior Director of Research
at Lumenis. He previously directed the worldwide sales and marketing
organizations and headed the clinical research and development efforts at the
Coherent Medical Group. He managed a 100-person sales and marketing team and
helped establish many innovative products, including the Novus 2000
Photocoagulator, the Laser Indirect Ophthalmoscope, and Laserlink delivery
system. Dr. Marcellino has authored 14 peer-reviewed articles in scientific
journals, two textbook chapters, and is an inventor on four patents. He received
his B.S., M.S. and Ph. D. in Sensory Physiology and Psychophysics, from the City
University of New York.
